SUMMARY Ten babies who required neonatal intensive care developed systemic candidiasis. Eight were extremely preterm (28 weeks' gestation or less) and all received prolonged ventilation, multiple courses of broad spectrum antibiotics, and intravenous hyperalimentation. Diagnosis was established by culture of yeasts from suprapubic urine specimens; venous blood cultures proved unreliable. Initial treatment with 5-flucytosine alone in eight babies and combined with amphotericin B in two, eradicated the infection in nine babies, the treatment failure arising through diagnostic delay and development of resistance to 5-flucytosine. Prophylactic topical antifungal drugs, regular screening of suprapubic urine specimens, and prompt use of systemic antifungal agents before multifocal infection becomes established may reduce the incidence and improve outcome.
Infection with unusual organisms is an increasing problem in neonatal intensive care units and presents new challenges to the neonatologist and microbiologist.' Systemic candidiasis causes particular problems, both in its presentation, which may be indistinguishable from bacterial septicaemia, and in the choice of treatment, which must be both effective and non-toxic. In addition, the high incidence of skin and gastrointestinal colonisation by candida, and hence contamination of specimens, makes it difficult to distinguish local from systemic infections, with the result that diagnosis may be delayed and appropriate treatment started late.
Between July 1981 and June 1984, 10 neonates and infants with systemic candidiasis were treated in the regional neonatal intensive care unit at this hospital. These babies are reviewed and the present scheme of management is described.
Patients, methods, and results
Patients. Details of the 10 babies are summarised in The age at diagnosis of systemic candidiasis ranged from 12 to 226 days, the organisms being Candida albicans in seven babies and Candida parapsilosis in the remaining three. Both species were isolated from two babies; in case 4, isolation of C parapsilosis from an eye swab prompted further screening which isolated C albicans; in case 3, C parapsilosis was isolated from cerebrospinal fluid obtained during operative removal of a ventriculoperitoneal shunt after C albicans had been identified in suprapubic urine and treatment begun. Treatment. Table 3 shows the drug and dosage regimens used, with the duration of treatment, adverse effects, and available drug concentrations. The initial treatment in all babies was 5-flucytosine, although in cases 2 and 6, amphotericin B was added within 48 hours when it became apparent that there was particularly widespread dissemination. Case 10 was well at the time the blood culture was undertaken, hence no treatment was started until clinical deterioration prompted a further infection screen. He failed to maintain a response to three separate courses of 5-flucytosine and by this stage a hard mass was palpable in his left flank. As the organism had become resistant to 5-flucytosine, amphotericin B was substituted, but without initial benefit. Laparotomy showed a large, pale, left kidney which was resected, allowing complete eradication of infection. Histology showed numerous small abscesses containing hyphae and yeast like bodies.
Initial doses of 5-flucytosine were 100 to 200 mg/kg/day. Blood concentrations were normally measured on the third day of treatment and both oral and intravenous routes produced peak values at the upper end of the therapeutic range of 50 to 100 mg/l. Because of the possibility of candida meningitis in case 4, drug concentrations were measured in cerebrospinal fluid from ventricular taps and were 20 to 67 mg/l. Amphotericin B was given as a single daily infusion and blood urea, electrolytes, and platelet count were monitored for signs of toxicity. The starting dose of 0-25 mg/kg was increased daily, if tolerated, to a maximum of 1 mg/kg/day.
Treatment was monitored by microscopy of serial suprapubic urine specimens and was stopped when three consecutive samples showed absence of hyphae and no growth on culture. Duration of treatment was 5 to 18 days in cases 1 to 9.
Possible toxic effects were seen in three babies with anaemia or transient thrombocytopaenia which was managed by dose reduction or temporary cessation of treatment. Interestingly, case 2 was thrombocytopaenic at diagnosis and her platelet count rose steadily during treatment.
Outcome. Two babies died during their first hospital admission and two died subsequently. No deaths were attributable to candidiasis or its treatment and there have been no recurrences in the survivors, nor any evidence of impaired immunity which would predispose to infection with yeasts.
Discussion
Babies at particular risk of systemic candidiasis are characteristically extremely preterm (28 weeks' gestation, or less) and have received long term ventilation, repeated courses of antibiotics, and total parenteral nutrition, though not necessarily via a central line.2-4 Confirmation of systemic candidiasis is difficult, with several previous reports drawing attention to negative blood and cerebrospinal fluid cultures before the discovery of disseminated disease at surgery or necropsy.2 3 6 12 Since candida has a predeliction for the urinary tract, it is essential that suprapubic urine should be examined in any baby suspected of fungal infection. We feel that the presence in urine of budding yeasts or hyphae is strongly suggestive of systemic infection and antifungal treatment should be started promptly pending the results of urine and blood cultures.
Venous blood cultures may at times be misleading' and in two of our patients were negative while arterial blood cultures were positive. Subsequent confirmation of a fungal infection from blood may take several days (up to 11 days in this series), and clearly, appropriate treatment should be started as soon as possible. Usually urine microscopy and subsequent culture results give a more prompt diagnosis and should always be undertaken. Total and differential leucocyte counts show no consistent changes in the presence of systemic candidiasis. Symptoms of systemic fungal infection are nonspecific, the presenting feature often being simply a poor colour or lethargy. Other infants, however, may present with a fulminating illness indistinguishable from bacterial septicaemia. Previous isolation of candida from superficial sites or endotracheal secretions should raise the level of suspicion and ensure that a search for evidence of systemic candidiasis is included in the infection screen of these infants.
Broad spectrum antibiotic usage probably predisposes to the development of systemic candidiasis. In our series, however, five babies were being treated for culture positive bacterial septicaemia at the time candidiasis was diagnosed and in contrast to previously published recommendations,5 12 there was no evidence that continuing antibiotics adversely affected the response to antifungal agents or subsequent outcome. Treatment remains the sub6ject of discussion and debate, with miconazole, 2 ketoconazole,7 5-flucytosine, and amphotericin B4 8 9 12 each having their advocates. While 5-flucytosine is known to cause bone marrow depression and to induce resistance after prolonged use, it has the advantages of excretion via the urinary tract and good absorption when given orally. Our experience suggests that 5-flucytosine alone is appropriate treatment for many babies who do not have a fulminating illness and in whom the diagnosis is made before multiorgan involvement has occurred. Amphotericin B is not absorbed from the gut and has poor penetration into body fluids when given parenterally. Although adverse effects in older children and adults include nephrotoxicity, hypotension, hypokalaemia, and thrombocytopaenia, amphotericin B was well tolerated and proved to be safe when used by gradually increasing the dose to 1 mg/kg/day. There is evidence that 5-flucytosine and amphotericin B act synergistically, both in vitro10 and in the mouse.1' The duration of treatment needed to eradicate systemic candidiasis is unknown12 and often arbitrary. It is probably wise to use 10 to 14 days treatment initially (though shorter courses may be successful). Several negative urine cultures confirm erradication, though this may on occasions be temporary. Even in the absence of obvious symptoms, urine should be cultured periodically thereafter for several weeks.
Prevention of candidiasis in susceptible babies is difficult, but we are attempting to reduce the degree of colonisation by applying povidone-iodine ointment to puncture sites of intravenous cannulae and also by using twice daily oral nystatin painted inside the mouth.
The trend towards aggressive treatment of extremely low birthweight babies has led to an increase in the incidence of systemic candidiasis. Positive urine cultures suggest systemic disease and should prompt arterial (not venous) blood cultures followed by antifungal treatment. Bacterial sepsis may coexist and, therefore, antibacterial treatment should not be withheld. Our experience shows that where fungal infection is recognised early, safe and effective treatment can readily be achieved.
